Correlations of glucose metabolism, insulin resistance and inflammatory factors with symptom score of patients with benign prostatic hyperplasia.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  European Review for Medical and Pharmacological Sciences

• Publication date

  2018-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.26355/eurrev_201808_15700PMID 30178825
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-inflammatory effects exerted by Killox®, an innovative formulation of food supplement with curcumin, in urology.

  2016cited by this paper
• Effect of obesity and hyperglycemia on benign prostatic hyperplasia in elderly patients with newly diagnosed type 2 diabetes.

  2015cited by this paper
• Correlations among cardiovascular risk factors, prostate blood flow, and prostate volume in patients with clinical benign prostatic hyperplasia.

  2012cited by this paper
• Metabolic syndrome and accompanying hyperinsulinemia have favorable effects on lower urinary tract symptoms in a generally healthy screened population.

  2011cited by this paper
• The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.

  2009cited by this paper
• [Xiaojin Wan inhibits the expression of COX-2 in prostate tissues of prostatitis pain rats].

  2008cited by this paper
• The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial.

  2008cited by this paper
• Prostate growth and inflammation.

  2008cited by this paper
• Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.

  2007cited by this paper
• Metabolic factors associated with benign prostatic hyperplasia.

  2006cited by this paper
• Atherosclerosis as a risk factor for benign prostatic hyperplasia

  2006cited by this paper
• Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia.

  2006cited by this paper
• Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer.

  2005cited by this paper
• Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). 1987.

  2005cited by this paper
• Role of gonadal hormones in development of the sexual phenotypes

  2004cited by this paper
• Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase‐2, Bcl‐2, and cell proliferation in the glandular epithelium

  2004cited by this paper
• Interleukin‐8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia

  2004cited by this paper
• Pathophysiological implications of insulin resistance on vascular endothelial function

  2003cited by this paper
• Hyperinsulinaemia as a Risk Factor for Developing Benign Prostatic Hyperplasia

  2001cited by this paper
• Proinflammatory Cytokine Levels in Patients with Lung Cancer and Carcinomatous Pleurisy

  1998cited by this paper
• Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).

  1987cited by this paper

• Midline-1 inhibited high glucose-induced epithelial-mesenchymal transition, fibrosis and inflammation through WNT/β-catenin signaling in benign prostatic hyperplasia

  2025cites this paper
• Association between insulin resistance and prostate volume: A 4‐year analysis from the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial

  2025cites this paper
• Glycemic control and prostate antigen levels in individuals with diabetes based on NHANES data

  2025cites this paper
• Overview of BPH: Symptom Relief with Dietary Polyphenols, Vitamins and Phytochemicals by Nutraceutical Supplements with Implications to the Prostate Microbiome

  2023cites this paper
• Antidiabetic drugs, glycemic control and risk of benign prostatic hyperplasia

  2022cites this paper
• LITERATURE REVIEW : HUBUNGAN DIABETES MELLITUS DENGAN KEJADIAN BENIGN PROSTATIC HYPERPLASIA

  2022cites this paper
• Insulin exacerbated high glucose-induced epithelial-mesenchymal transition in prostatic epithelial cells BPH-1 and prostate cancer cells PC-3 via MEK/ERK signaling pathway.

  2020cites this paper